Literature DB >> 15753006

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses.

Hans-Ulrich Bernard1.   

Abstract

Human papillomaviruses (HPVs) are formally described by isolation of their circular double-stranded DNA genomes and establishment and comparison of the nucleotide sequence of these genomes. Alternatives such as serological diagnosis and maintenance of HPVs in culture are neither clinically useful nor consistently feasible. Novel HPV isolates have traditionally been described as "types". The analysis of specific HPV types is of medical importance, because HPV types typically induce type-specific lesions, i.e. they may be specific for cutaneous or mucosal epithelia, or give rise to benign warts or malignant carcinomas. Recently, it was formally decided that papillomaviruses are a virus family separate from the polyomaviruses. Within the papillomavirus family, closely or remotely related types form species or genera. These formal agreements were important as they brought the taxonomy of papillomaviruses in line with that of other viruses, bacteria and higher organisms, although their impact on medical practice and terminology used in clinical studies is limited. Notably, however, HPV types that are closely related (i.e. form "species") are associated with similar lesions. Confusion of the terms "type" and "subtype" should be avoided, as the latter term refers to some specific but rare taxonomic assemblages. In contrast to many RNA viruses, HPV types evolve very slowly, and diverged since the origin of humans only by about 2%. These divergent isolates are called "variants". HPVs evolved together with humankind and Homo sapiens was never without HPVs, and consequently never without warts and cervical cancer. Variants of the same HPV type may have different pathogenicity and may account for part of the worldwide disparities in the occurrence of genital cancers.

Entities:  

Mesh:

Year:  2005        PMID: 15753006     DOI: 10.1016/j.jcv.2004.10.021

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  44 in total

1.  Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.

Authors:  M G McPhillips; J G Oliveira; J E Spindler; R Mitra; A A McBride
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Novel papillomavirus isolates from Erinaceus europaeus (Erinaceidae, Insectivora) and the Cervidae (Artiodactyla), Cervus timorensis and Pudu puda, and phylogenetic analysis of partial sequence data.

Authors:  Marc Gottschling; Gudrun Wibbelt; Ulrich Wittstatt; Eggert Stockfleth; Ingo Nindl
Journal:  Virus Genes       Date:  2008-01-22       Impact factor: 2.332

3.  New variants of human papillomavirus type 18 identified in central Brazil.

Authors:  Daniela Marreco Cerqueira; Tainá Raiol; Nazle Mendonça Collaço Véras; Natália von Gal Milanezi; Fádia Aguiar Amaral; Marcelo de Macedo Brígido; Cláudia Renata Fernandes Martins
Journal:  Virus Genes       Date:  2008-07-29       Impact factor: 2.332

4.  Top Tips in 2 minutes.

Authors:  Chris Sonnex
Journal:  Br J Gen Pract       Date:  2008-09       Impact factor: 5.386

5.  Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil.

Authors:  Rodrigo Lopes da Silva; Zulmira da Silva Batista; Gerusinete Rodrigues Bastos; Ana Paula Almeida Cunha; Fábio Vidal Figueiredo; Lailson Oliveira de Castro; Liwerbeth Dos Anjos Pereira; Marcos Antonio Custódio Neto da Silva; Flávia Castello Branco Vidal; Maria Claudene Barros; Elmary da Costa Fraga; Luciane Maria Oliveira Brito; Maria do Carmo Lacerda Barbosa; Miguel Ângelo Martins Moreira; Maria do Desterro Soares Brandão Nascimento
Journal:  BMC Womens Health       Date:  2020-08-01       Impact factor: 2.809

6.  Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.

Authors:  Ingeborg Zehbe; Christina Richard; Correne A DeCarlo; Anny Shai; Paul F Lambert; Hava Lichtig; Massimo Tommasino; Levana Sherman
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

7.  Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain.

Authors:  Pablo Conesa-Zamora; Sebastián Ortiz-Reina; Joaquín Moya-Biosca; Asunción Doménech-Peris; Francisco Javier Orantes-Casado; Miguel Pérez-Guillermo; Marcos Egea-Cortines
Journal:  BMC Infect Dis       Date:  2009-08-10       Impact factor: 3.090

8.  Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.

Authors:  Luciano Mariani; Núria Monfulleda; Laia Alemany; Enrico Vizza; Ferdinando Marandino; Amina Vocaturo; Maria Benevolo; Beatriz Quirós; Belén Lloveras; Jo Ellen Klaustermeier; Wim Quint; Silvia de Sanjosé; F Xavier Bosch
Journal:  BMC Cancer       Date:  2010-06-04       Impact factor: 4.430

Review 9.  A technological update of molecular diagnostics for infectious diseases.

Authors:  Yu-Tsueng Liu
Journal:  Infect Disord Drug Targets       Date:  2008-09

10.  Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation.

Authors:  Mina Kalantari; Alejandro Garcia-Carranca; Claudia Dalia Morales-Vazquez; Rosemary Zuna; Delia Perez Montiel; Itzel E Calleja-Macias; Bo Johansson; Sonia Andersson; Hans-Ulrich Bernard
Journal:  Virology       Date:  2009-06-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.